Evidence map›Paper›PMID 39734356›Full record

ArticleTurkish journal of medical sciences2024

Association between papillary thyroid cancer and

Egemen Akgün, Fadime Mutlu Içduygu, Demet Şengül, Ebru Alp, Mehmet Alkanat, Ayşegül Çebi, Tuncer Öztürk

Abstract read
In one paragraph

Article in Turkish journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Egemen AkgünDepartment of Medical Biology, Faculty of Medicine, Giresun University, Giresun, Turkiye.ORCID https://orcid.org/0000-0003-1979-419X
Fadime Mutlu IçduyguDepartment of Medical Genetics, Faculty of Medicine, Giresun University, Giresun, Turkiye.ORCID https://orcid.org/0000-0002-4913-9420
Demet ŞengülDepartment of Pathology, Faculty of Medicine, Giresun University, Giresun, Turkiye.ORCID https://orcid.org/0000-0002-0416-0621
Ebru AlpDepartment of Medical Biology, Faculty of Medicine, Giresun University, Giresun, Turkiye.ORCID https://orcid.org/0000-0001-7303-666X
Mehmet AlkanatDepartment of Physiology, Faculty of Medicine, Giresun University, Giresun, Turkiye.ORCID https://orcid.org/0000-0001-8079-3749
Ayşegül ÇebiGiresun University Faculty of Health Sciences, Giresun, Turkiye.ORCID https://orcid.org/0000-0003-3804-7966
Tuncer ÖztürkDepartment of General Surgery, Faculty of Medicine, Giresun University, Giresun, Turkiye.ORCID https://orcid.org/0000-0002-2765-216X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: To investigate the association between the rs2267437, rs5751129 and rs132770 polymorphisms of the Materials and methods: The study included 150 patients who had been diagnosed with PTC and 204 healthy controls. Genotyping of the SNPs was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: In the rs2267437 polymorphism, individuals with the GG genotype had lower risk of PTC than those with the wild-type CC genotype (p = 0.037, 95% CI: 0.19-0.96, OR: 0.67). The combined genotypes CG+GG were related to a reduced risk of PTC compared to the wild-type CC genotype (p = 0.023, 95% CI: 0.40-0.94, OR: 0.61) in the recessive model (GC+GG vs. CC). In addition, a query of the genotype-tissue expression (GTEx) database showed that the rs2267437 polymorphism may alter the expression level of Conclusion: This study demonstrated that rs2267437 polymorphism may have a protective effect against PTC in the Turkish population. However, the rs5751129 and rs132770 polymorphisms were not associated with the disease.

Indexed as

Genetic Predisposition to DiseaseKu AutoantigenPolymorphism, Single NucleotideThyroid Cancer, PapillaryThyroid NeoplasmsAdultCase-Control StudiesFemaleGenotypeHumansMaleMiddle AgedTurkeyKu AutoantigenXrcc6 protein, humangenotype-tissue expressionpapillary thyroid cancerPCR-RFLPpolymorphismXRCC6

Identifiers

PMID39734356
PMCPMC11673619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.